ALLMedicine™ Hyperparathyroidism Center
Research & Reviews 3,615 results
https://clinicaltrials.gov/ct2/show/NCT01660984
Jul 1st, 2022 - Background: Medullary Thyroid Carcinoma (MTC) is a calcitonin producing tumor arising from the parafollicular C cells of thyroid. In children and adults, MTC is usually seen in association with Multiple Endocrine Neoplasia (MEN) 2A and 2B, which a...
https://clinicaltrials.gov/ct2/show/NCT00001345
Jul 1st, 2022 - Familial multiple endocrine neoplasia type 1 (MEN1), familial hypocalciuric (or familial benign) hypercalcemia (FHH), hyperparathyroidism - jaw tumor syndrome (HPT-JT), other causes of familial isolated hyperparathyroidism (FIHP), and pseudohypopa...
https://doi.org/10.1007/s00268-022-06633-7 10.1111/j.1365-2265.2008.03324.x 10.1038/s41574-021-00468-3 10.1067/msy.1998.93107 10.1097/SLA.0b013e31815efda5 10.1111/j.1365-2265.2009.03672.x 10.1007/s12020-017-1377-3 10.1210/jc.2016-1477 10.1210/jc.2015-3909 10.1016/S0002-9440(10)64406-9 10.3389/fendo.2019.00123 10.1007/s00268-011-1068-9 10.1016/j.ijsu.2010.02.007 10.1001/jama.283.15.2008 10.1097/SLA.0b013e31824c5145 10.1007/s00268-016-3624-9 10.1038/s41598-020-67424-5 10.1186/1750-1172-8-50 10.1111/j.1365-2265.2006.02438.x 10.1007/s00268-017-4366-z 10.1067/msy.2002.128607 10.1530/EC-19-0321 10.1007/s00104-004-0838-4 10.1007/BF01655552 10.1111/cen.14112 10.1001/archsurg.141.3.235 10.1002/bjs.7154 10.1001/archsurg.140.4.374 10.1007/s00268-015-3297-9 10.1080/110241501750099294 10.1016/j.surg.2013.03.004 10.1016/j.ciresp.2018.06.014 10.1245/ASO.2006.12.009 10.1016/s0039-6060(03)00406-9 10.1016/j.surg.2014.08.006 10.1001/jamasurg.2016.2310 10.1530/EJE-18-0580 10.1210/jc.2012-1808 10.1002/jbmr.1979 10.4158/EP13328.OR 10.1002/jbmr.2273 10.1016/j.jamcollsurg.2014.07.412 10.1007/s00268-012-1451-1 10.1007/s00259-018-4123-z 10.1007/s00268-020-05695-9 10.2967/jnumed.119.225771 10.1002/lary.28566 10.1007/s10897-006-9047-2 10.1016/j.surg.2020.08.021 10.3389/fendo.2018.00558 10.1016/S0039-6060(98)70040-6
World Journal of Surgery; Bouriez D, Gronnier C et. al.
Jun 30th, 2022 - Multiple endocrine neoplasia type 1 (MEN1)-associated primary hyperparathyroidism (pHPT) is classically associated with an asymmetric and asynchronous parathyroid involvement. Subtotal parathyroidectomy (STP), which is currently the recommended su...
https://doi.org/10.1007/s00268-022-06629-3 10.1155/2013/921260 10.2967/jnmt.111.098400 10.2967/jnmt.112.118208 10.1097/RLU.0000000000000988 10.2967/jnumed.112.109561 10.1001/archsurg.135.12.1461 10.1007/s00259-021-05334-y 10.1308/rcsann.2019.0059 10.2967/jnumed.120.245993 10.1016/j.amjsurg.2018.06.027 10.2967/jnumed.120.257303 10.2967/jnumed.120.256735
World Journal of Surgery; Goren S, Paladino NC et. al.
Jun 29th, 2022 - Minimally invasive parathyroidectomy (MIP) has gained acceptance as the preferred surgical procedure for management of primary hyperparathyroidism (pHPT). Appropriate selection of patients for a MIP is a crucial step in its utilization. The aim of...
https://doi.org/10.1007/s40262-022-01139-w 10.2215/CJN.06040710 10.1016/S0140-6736(09)60507-9 10.1046/j.1523-1755.2001.0590031187.x 10.1111/1744-9987.12058 10.1097/01.asn.0000050224.03126.ad 10.1056/NEJMoa031633 10.1681/ASN.2004060512 10.1038/kisup.2013.91 10.1093/ndt/gfm534 10.1111/j.1542-4758.2009.00397.x 10.1016/j.ekir.2016.04.002 10.1002/jcph.460 10.1007/s40620-019-00677-0 10.1111/1744-9987.13434 10.1001/jama.2016.19468 10.1172/JCI119413 10.1371/journal.pone.0195316 10.1016/j.bmcl.2018.04.055 10.1053/j.ajkd.2017.07.019 10.7326/0003-4819-104-3-358 10.1053/ajkd.1998.v32.pm9669433 10.1007/s10741-013-9371-1 10.1016/j.mayocp.2017.05.028
Clinical Pharmacokinetics; Kazama JJ, Koiwa F et. al.
Jun 29th, 2022 - Upacicalcet is a new renally excreted and injectable calcimimetic agent. We evaluated the pharmacokinetics, pharmacodynamics, safety, and tolerability of single and multiple intravenous administration of upacicalcet in patients with secondary hype...
Guidelines 6 results
https://doi.org/10.1016/j.jacr.2021.08.013
Journal of the American College of Radiology : JACR; , Zander D et. al.
Nov 20th, 2021 - Hyperparathyroidism is defined as excessive parathyroid hormone production. The diagnosis is made through biochemical testing, in which imaging has no role. However, imaging is appropriate for preoperative parathyroid gland localization with the i...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118036
Journal of Nephrology; Bellasi A, Cozzolino M et. al.
Dec 20th, 2019 - Bone mineral abnormalities (defined as Chronic Kidney Disease Mineral Bone Disorder; CKD-MBD) are prevalent and associated with a substantial risk burden and poor prognosis in CKD population. Several lines of evidence support the notion that a lar...
https://doi.org/10.1093/ageing/afu093
Age and Ageing; Aspray TJ, Bowring C et. al.
Jul 31st, 2014 - The National Osteoporosis Society (NOS) published its document, Vitamin D and Bone Health: A Practical Clinical Guideline for Patient Management, in 2013 as a practical clinical guideline on the management of vitamin D deficiency in adult patients...
https://www.ncbi.nlm.nih.gov/pubmed/22824948
Journal of Endocrinological Investigation; Zini M, Attanasio R et. al.
Jul 25th, 2012 - AME position statement: primary hyperparathyroidism in clinical practice.|2012|Zini M,Attanasio R,Cesareo R,Emmolo I,Frasoldati A,|therapeutic use,etiology,therapeutic use,therapeutic use,complications,diagnosis,drug therapy,surgery,etiology,blood,
https://doi.org/10.1136/ard.2010.139105
Annals of the Rheumatic Diseases; Zhang W, Doherty M et. al.
Jan 11th, 2011 - To agree terminology and to develop recommendations for the diagnosis of calcium pyrophosphate deposition (CPPD). The European League Against Rheumatism (EULAR) CPPD Task Force, comprising 15 experts from 10 countries, agreed the terms and recomme...
Drugs 151 results see all →
Clinicaltrials.gov 354 results
https://clinicaltrials.gov/ct2/show/NCT00001345
Jul 1st, 2022 - Familial multiple endocrine neoplasia type 1 (MEN1), familial hypocalciuric (or familial benign) hypercalcemia (FHH), hyperparathyroidism - jaw tumor syndrome (HPT-JT), other causes of familial isolated hyperparathyroidism (FIHP), and pseudohypopa...
https://clinicaltrials.gov/ct2/show/NCT01660984
Jul 1st, 2022 - Background: Medullary Thyroid Carcinoma (MTC) is a calcitonin producing tumor arising from the parafollicular C cells of thyroid. In children and adults, MTC is usually seen in association with Multiple Endocrine Neoplasia (MEN) 2A and 2B, which a...
https://clinicaltrials.gov/ct2/show/NCT05426512
Jun 22nd, 2022 - Postmenopausal women with primary hyperparathyroidism will be included in the study. The diagnosis of primary hyperparathyroidism is based on the high levels of parathyroid hormone and calcium. Postmenopausal women with kidney failure, liver failu...
https://clinicaltrials.gov/ct2/show/NCT02133404
Jun 14th, 2022 - This study is a multicenter, double-blind, randomized, Cinacalcet hydrochloride-controlled, parallel-group, dose-ascending study. Subjects judged to be eligible will be registered and randomized into either ASP7991 group (receiving ASP7991 and cin...
https://clinicaltrials.gov/ct2/show/NCT00001277
Jun 7th, 2022 - Observational: Patients with confirmed or suspected primary hyperparathyroidism or complications therefrom (such as postoperative hypoparathyroidism) will be admitted for diagnosis and treatment. The principal diagnostic components are calcium in ...
News 210 results
https://www.medscape.com/viewarticle/976361
Jun 29th, 2022 - Dr Mattias Lorentzon Patients with untreated primary hyperparathyroidism show significant increases in the risk of hip fracture, cardiovascular events, and mortality, however, the risk is reduced when treated with parathyroidectomy, results from a...
https://www.medscape.com/viewarticle/974803
May 31st, 2022 - Researchers published the study covered in this summary on researchsquare.com as a preprint that has not yet been peer reviewed. Key Takeaways Researchers have developed and validated a predictive model to estimate the amount of postoperative intr...
https://www.medscape.com/viewarticle/972299
Apr 18th, 2022 - Patients who receive parathyroidectomy for mild primary hyperparathyroidism show no benefits in survival or morbidity, including fractures, cancer, or cardiovascular outcomes over more than 10 years, when compared with those not receiving the surg...
https://www.mdedge.com/psychiatry/article/251979/movement-disorders/top-strategies-preventing-tardive-dyskinesia
Doug Brunk
Feb 18th, 2022 - LAS VEGAS – In the opinion of Christoph U. Correll, MD, tardive dyskinesia (TD) “has been somewhat forgotten” by psychiatrists because the risk of patients developing the condition is considered to be significantly lower with second-generation ant.
https://www.medscape.com/viewarticle/966484
Jan 13th, 2022 - NEW YORK (Reuters Health) - An expert panel has developed quality indicators (QIs) for the diagnosis and management for primary hyperparathyroidism (pHPT), which they hope will help optimize quality and cost-effectiveness of care for patients. "To...